Company Filing History:
Years Active: 2018-2021
Title: Shiming Peng: Innovator in Pharmaceutical Compounds
Introduction
Shiming Peng is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address critical health issues such as obesity and macular degeneration. With a total of five patents to his name, Peng's work is recognized for its potential impact on public health.
Latest Patents
Among his latest inventions, Shiming Peng has developed FTO inhibitors, which provide compounds that inhibit FTO (fat mass and obesity). These compounds include pharmaceutically acceptable salts, hydrides, and stereoisomers. They are employed in pharmaceutical compositions and methods aimed at treating individuals suffering from obesity, with the goal of improving their health conditions. Another notable patent involves entacapone-related compounds designed to treat macular degeneration. This invention utilizes entacapone, its derivatives, or stereoisomers to treat or inhibit macular degeneration, particularly age-related macular degeneration.
Career Highlights
Shiming Peng is affiliated with the National Institute of Biological Sciences in Beijing. His work at this esteemed institution has allowed him to focus on innovative research and development in the pharmaceutical sector. His contributions have been instrumental in advancing the understanding and treatment of various health conditions.
Collaborations
Shiming Peng collaborates with notable colleagues, including Niu Huang and Gang Zhi. Their combined expertise enhances the research efforts at the National Institute of Biological Sciences, fostering an environment of innovation and discovery.
Conclusion
In summary, Shiming Peng is a distinguished inventor whose work in pharmaceutical compounds has the potential to significantly improve health outcomes for individuals facing obesity and macular degeneration. His contributions to science and medicine are invaluable and continue to inspire future innovations.